Acrylamide-induced effects on general and neurospecific cellular functions during exposure and recovery
暂无分享,去创建一个
E. Walum | P. Kjellstrand | A. Forsby | M. Nordin-Andersson | P. Kjellstrand | M. Nordin-Andersson | E. Walum | A. Forsby
[1] J. DeJongh,et al. Estimation of systemic toxicity of acrylamide by integration of in vitro toxicity data with kinetic simulations. , 1999, Toxicology and applied pharmacology.
[2] C. Calleman,et al. The metabolism and pharmacokinetics of acrylamide: implications for mechanisms of toxicity and human risk estimation. , 1996, Drug metabolism reviews.
[3] P. Spencer,et al. A Review of Acrylamide Neurotoxicity Part I. Properties, Uses and Human Exposure , 1974, Canadian Journal of Neurological Sciences / Journal Canadien des Sciences Neurologiques.
[5] H. Tilson,et al. The impact of dose rate on the neurotoxicity of acrylamide: the interaction of administered dose, target tissue concentrations, tissue damage, and functional effects. , 1996, Toxicology and applied pharmacology.
[6] M. Goldberg,et al. Calpain Activation Contributes to Dendritic Remodeling after Brief Excitotoxic Injury In Vitro , 1997, The Journal of Neuroscience.
[7] Tilson Ha. The neurotoxicity of acrylamide: an overview. , 1981 .
[8] L S Freedman,et al. Multiple neurotransmitter synthesis by human neuroblastoma cell lines and clones. , 1978, Cancer research.
[9] O. H. Lowry,et al. Protein measurement with the Folin phenol reagent. , 1951, The Journal of biological chemistry.
[10] J. Eichberg,et al. Changes in Na-K ATPase and protein kinase C activities in peripheral nerve of acrylamide-treated rats. , 1994, Journal of toxicology and environmental health.
[11] G H Sato,et al. Growth of a rat neuroblastoma cell line in serum-free supplemented medium. , 1979, Proceedings of the National Academy of Sciences of the United States of America.
[12] F. Oehme,et al. Acrylamide and Polyacrylamide: A Review of Production, Use, Environmental Fate and Neurotoxicity , 1991, Reviews on environmental health.
[13] Pierluigi Nicotera,et al. In Vitro Neurotoxicity Testing , 1994 .
[14] S. Nahorski,et al. Muscarinic-receptor-mediated changes in intracellular Ca2+ and inositol 1,4,5-trisphosphate mass in a human neuroblastoma cell line, SH-SY5Y. , 1990, The Biochemical journal.
[15] E. Walum,et al. Determination of Critical Cellular Neurotoxic Concentrations in Human Neuroblastoma (SH-SY5Y) Cell Cultures , 1995 .
[16] P. Fullerton. Electrophysiological and histological observations on peripheral nerves in acrylamide poisoning in man. , 1969, Journal of neurology, neurosurgery, and psychiatry.
[17] E. Lehning,et al. Acrylamide-induced distal axon degeneration: a proposed mechanism of action. , 1994, Neurotoxicology.
[18] Cavanagh Jb. The significance of the "dying back" process in experimental and human neurological disease. , 1964 .
[19] J. Krieglstein,et al. Blockade of calpain proteolytic activity rescues neurons from glutamate excitotoxicity , 1997, Neuroscience Research.
[20] A. Ruusala,et al. Retinoic acid-induced differentiation of cultured human neuroblastoma cells: a comparison with phorbolester-induced differentiation. , 1984, Cell differentiation.
[21] M. Blaustein,et al. Physiological effects of endogenous ouabain: control of intracellular Ca2+ stores and cell responsiveness. , 1993, The American journal of physiology.
[22] P. Spencer,et al. Ultrastructural studies of the dying-back process. IV. Differential vulnerability of PNS and CNS fibers in experimental central-peripheral distal axonopathies. , 1977, Journal of neuropathology and experimental neurology.
[23] J. DeJongh,et al. Neurite degeneration in differentiated human neuroblastoma cells. , 1998, Toxicology in vitro : an international journal published in association with BIBRA.
[24] J. Cavanagh. THE PATHOKINETICS OF ACRYLAMIDE INTOXICATION: A REASSESSMENT OF THE PROBLEM , 1982, Neuropathology and applied neurobiology.
[25] D. W. Sickles. Toxic neurofilamentous axonopathies and fast anterograde axonal transport. I. The effects of single doses of acrylamide on the rate and capacity of transport. , 1991, Neurotoxicology.
[26] P. Spencer,et al. Ultrastructural studies of the dying-back process. III. The evolution of experimental peripheral giant axonal degeneration. , 1977, Journal of neuropathology and experimental neurology.
[27] S. Orrenius,et al. The role of calcium in the regulation of apoptosis , 1996, Scanning microscopy.
[28] E. Walum,et al. Glutathione content, glutathione transferase activity and lipid peroxidation in acrylamide-treated neuroblastoma N1E 115 cells. , 1994, Toxicology in vitro : an international journal published in association with BIBRA.
[29] S. Orrenius,et al. Calcium signalling and the regulation of apoptosis. , 1998, Toxicology in vitro : an international journal published in association with BIBRA.
[30] W. Gispen,et al. Polyneuropathies and CNS protein metabolism. III. Changes in protein synthesis rate induced by acrylamide intoxication. , 1978, Journal of neuropathology and experimental neurology.
[31] M. Fehlings,et al. Pretreatment with Calpain Inhibitor CEP‐4143 Inhibits Calpain I Activation and Cytoskeletal Degradation, Improves Neurological Function, and Enhances Axonal Survival After Traumatic Spinal Cord Injury , 2000, Journal of neurochemistry.
[32] B. Veronesi,et al. In vitro screening batteries for neurotoxicants. , 1992, Neurotoxicology.